CYTO News and Press, Altamira Therapeutics Ltd. From 05/01/24

Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd. (“Altamira” or t...

2024-04-24 10:11:05 ET More on Altamira Therapeutics Altamira stock rallies 44% on Univercells mRNA collaboration Seeking Alpha’s Quant Rating on Altamira Therapeutics Financial information for Altamira Therapeutics Read the full article on Seeking A...

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated ...

2024-04-10 11:18:10 ET Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Conference Call April 10, 2024, 08:30 AM ET Company Participants Thomas Meyer - Founder, Chairman & Chief Executive Officer Covadonga Pañeda - Chief Operating Officer Presentatio...

2024-04-10 08:04:14 ET More on Altamira Therapeutics Altamira stock rallies 44% on Univercells mRNA collaboration Altamira Therapeutics stock jumps 7% as it files for second patent Financial information for Altamira Therapeutics Read the full article on See...

Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDT RNA delivery business progressing with new collaborations, potential new applications Partnering of legacy assets underway as Company transitions to f...

2024-04-09 09:33:28 ET Major earnings expected before the bell on Wednesday include: Applied Digital Corporation ( APLD ) Altamira Therapeutics Ltd. ( CYTO ) Delta Air Lines ( DAL ) For Seeking Alpha's full earnings season calendar, click here . Rea...

Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it will host its Full Year 2023 Financial Resul...

A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 29.5% to $0.0509 on volume of 289,179,589 shares Nikola Corporation (NKLA) rose 12.3% to $0.7436 on volume of 164,247,182 shares KULR Technology Group Inc. (KULR) rose 55.6% to $0.3251 on volume of 123,355,3...

2024-03-25 12:19:30 ET More on Altamira Therapeutics Altamira Therapeutics stock jumps 7% as it files for second patent Financial information for Altamira Therapeutics Read the full article on Seeking Alpha For further details see: Altamira stock rallies ...